Jefferies Group LLC Orgenesis Inc. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
Shares
2 transactions
Others Institutions Holding ORGS
# of Institutions
20Shares Held
1.61MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA910KShares$4.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA283KShares$1.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY79.9KShares$423,4110.0% of portfolio
-
State Street Corp Boston, MA78.9KShares$418,0530.0% of portfolio
-
Ronit Capital LLP54.2KShares$287,0850.1% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $135M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...